Cytokine Patterns in Brain Tumour Progression
Open Access
- 24 June 2013
- journal article
- research article
- Published by Hindawi Limited in Mediators of Inflammation
- Vol. 2013, 1-7
- https://doi.org/10.1155/2013/979748
Abstract
Inflammation represents the immune system response to external or internal aggressors such as injury or infection in certain tissues. The body’s response to cancer has many parallels with inflammation and repair; the inflammatory cells and cytokines present in tumours are more likely to contribute to tumour growth, progression, and immunosuppression, rather than in building an effective antitumour defence. Using new proteomic technology, we have investigated serum profile of pro- (IL-1β, IL-6, IL-8, IL-12, GM-CSF, and TNF-α) and anti-inflammatory cytokines (IL-4, IL-10), along with angiogenic factors (VEGF, bFGF) in order to assess tumoural aggressiveness. Our results indicate significant dysregulation in serum levels of cytokines and angiogenic factors, with over threefold upregulation of IL-6, IL-1β, TNF-α, and IL-10 and up to twofold upregulation of VEGF, FGF-2, IL-8, IL-2, and GM-CSF. These molecules are involved in tumour progression and aggressiveness, and are also involved in a generation of disease associated pain.Keywords
This publication has 49 references indexed in Scilit:
- An Exploratory Study of Inflammatory Cytokines as Prognostic Biomarkers in Patients With Ductal Pancreatic AdenocarcinomaPancreas, 2012
- p38 MAPK inhibitors attenuate pro-inflammatory cytokine production and the invasiveness of human U251 glioblastoma cellsJournal of Neuro-Oncology, 2012
- Prospective study evaluating the plasma concentrations of twenty-six cytokines and response to morphine treatment in cancer patients.2011
- GM-CSF Production by Glioblastoma Cells Has a Functional Role in Eosinophil Survival, Activation, and Growth Factor Production for Enhanced Tumor Cell ProliferationThe Journal of Immunology, 2011
- Targeting the inflammatory pathways to enhance chemotherapy of cancer.Cancer Biology & Therapy, 2011
- Immunity, Inflammation, and CancerCell, 2010
- Interleukin-6 gene amplification and shortened survival in glioblastoma patientsBritish Journal of Cancer, 2007
- Th1/Th2 cytokine imbalance in meningioma, anaplastic astrocytoma and glioblastoma multiforme patientsOncology Reports, 2006
- An initial investigation of spinal mechanisms underlying pain enhancement induced by fractalkine, a neuronally released chemokineEuropean Journal of Neuroscience, 2005
- Interleukin-4-Pseudomonas exotoxin chimeric fusion protein for malignant glioma therapy.Journal of Neuro-Oncology, 2003